ACUTE BIPHENOTYPIC LEUKEMIA
Clinical trials for ACUTE BIPHENOTYPIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE BIPHENOTYPIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE BIPHENOTYPIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to stop leukemia relapse after transplant
Disease control OngoingThis study tests whether two drugs, venetoclax and azacitidine, can help prevent leukemia from returning in 100 adults who have already had a stem cell transplant. Participants have high-risk acute myeloid leukemia or related blood cancers and are in remission after transplant. T…
Matched conditions: ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:39 UTC
-
Engineered t cells take aim at Hard-to-Treat leukemias
Disease control OngoingThis early-stage study tests a new type of immunotherapy for people with certain leukemias that have come back or not responded to standard treatment. The therapy uses a patient's own or donor's immune cells that are genetically modified to recognize and attack cancer cells carry…
Matched conditions: ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 08:35 UTC
-
Frozen donor marrow trial aims to treat blood cancers
Disease control TerminatedThis study tested a bone marrow transplant using frozen, banked bone marrow from unrelated donors for people with blood cancers like leukemia. The goal was to see if it safely restores healthy blood cells and controls the disease. The trial was withdrawn before enrolling any part…
Matched conditions: ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE1 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated May 22, 2026 14:05 UTC